NCT02009423View on ClinicalTrials.gov

Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence

PHASE3TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Gastro-Intestinal Stromal Tumour
Interventions
DRUG

Masitinib

DRUG

Placebo

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY